Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. (Q46919151)
scientific article published on 30 January 2006
Language:
(P31) (Q13442814)
(P50) (Q61196675)
(P304) 536-545
(P407) (Q1860)
(P433) 3
(P478) 57
(P577) Monday, January 30, 2006
(P921) (Q221179)
(Q2870929)
(P1433) (Q6294770)
(P1476) "Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae" (language: en)
(P2093) B Siquier
J Sánchez-Alvarez
E García-Mendez
M Sabriá
J Santos
M Twynholm
R Dal-Ré
620 Clinical Study Group
other details
description scientific article published on 30 January 2006

External Links